Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | MMP14 | P50281 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28386422 | 0.89 | CYP3A4 (0.48) | LMNACYP3A4L3MBTL1ALDH1A1TDP1 | |
| SCHEMBL24178865 | 0.79 | LMNA (0.42) | LMNACYP3A4L3MBTL1ALDH1A1TDP1 | |
| SCHEMBL24178792 | 0.79 | LMNA (0.42) | LMNACYP3A4L3MBTL1ALDH1A1TDP1 | |
| SCHEMBL7529088 | 0.79 | DNM1 (0.44) | DNM1TSHR | |
| SCHEMBL24178791 | 0.76 | LMNA (0.46) | LMNACYP3A4L3MBTL1ALDH1A1TDP1 | |
| SCHEMBL7526349 | 0.76 | DNM1 (0.41) | CYP3A4ALDH1A1TDP1DNM1CA2 | |
| SCHEMBL7534555 | 0.76 | ALDH1A1 (0.34) | LMNACYP3A4L3MBTL1ALDH1A1TDP1 | |
| SCHEMBL24178793 | 0.76 | OPRM1 (0.35) | LMNADNM1TSHRSMPD1 | |
| SCHEMBL5186405 | 0.75 | LMNA (0.45) | LMNACYP3A4L3MBTL1ALDH1A1TDP1 | |
| SCHEMBL18327084 | 0.74 | LMNA (0.48) | LMNACYP3A4L3MBTL1PRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3883913-B1 | PROCESS FOR MAKING ETHERS VIA ENOL ETHERS | BP PLC (GB) | 2023-11-01 | — | — | EP | disclosed |
| US-11787760-B2 | Process for making ethers via enol ethers | BP P.L.C. (GB) | 2023-10-17 | — | — | US | disclosed |
| US-11787760-B2 | Process for making ethers via enol ethers | BP P.L.C. (GB) | 2023-10-17 | — | — | US | disclosed |
| US-20220002220-A1 | Process for Making Ethers via Enol Ethers | BP P.L.C. (GB) | 2022-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787760-B2 | Process for making ethers via enol ethers | ELOVL5, ELOVL1, ELOVL3 | LMNA 1249/4885CYP3A4 460/4885L3MBTL1 1544/4885 |
| US-20220002220-A1 | Process for Making Ethers via Enol Ethers | ELOVL5, ELOVL1, ELOVL3 | LMNA 1249/4885CYP3A4 460/4885L3MBTL1 1544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.